KDventures ABLTS:0P3C 42 EBITDA Margin % is -1,210.72% as of Mar. 2026. GuruFocus rates LTS:0P3C with a GF Score™ of 42/100 and a GF Value™ of kr0.77 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, KDventures AB ranks worse than 81.04% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. KDventures AB's EBITDA for the
three
months ended in Mar. 2026 was kr-5.19 Mil. KDventures AB's Revenue for the
three
months ended in Mar. 2026 was kr0.43 Mil. Therefore, KDventures AB's EBITDA margin for the quarter that ended in Mar. 2026 was -1,210.72%.
KDventures AB (LTS:0P3C) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
KDventures AB EBITDA Margin % Related Terms
KDventures AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for KDventures AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0P3C vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, KDventures AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where KDventures AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (LTS:0P3C) has a EBITDA Margin % of -1,210.72% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KDventures AB and its competitors. According to the industry distribution chart, KDventures AB ranks #765 out of 944 companies in the Biotechnology industry, placing it in the top 81%.
Is KDventures AB's EBITDA Margin % too high?
KDventures AB's current EBITDA Margin % is -1,210.72%. Based on the distribution chart, KDventures AB ranks #765 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, KDventures AB has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #765 out of 944 companies for EBITDA Margin %. This places KDventures AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KDventures AB and its competitors. KDventures AB's current EBITDA Margin % is -1,210.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
Based on GuruFocus' analysis, KDventures AB (LTS:0P3C) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.77, compared to a current price of kr0.27 — trading 65.3% below its estimated fair value. The current EBITDA Margin % is -1,210.72%. KDventures AB's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For KDventures AB (LTS:0P3C), the current EBITDA Margin % is -1,210.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (LTS:0P3C) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of kr0.27 is trading 65.3% below its estimated GF Value™ of kr0.77.
GuruFocus considers KDventures AB to be Possible Value Trap.
Key valuation signals for LTS:0P3C:
EBITDA Margin %: -1,210.72%
GF Value™: kr0.77 vs. price of kr0.27 (65.3% below fair value)
No single metric tells the full story. See the LTS:0P3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
42GF Score
Get the complete analysis for LTS:0P3C
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0P3C has been successfully added to your 
